After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Anavex Life Sciences Corporation is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Anavex Life Sciences Corporation is $742.61M. A total of 0.8 million shares were traded on the day, compared to an average of 1.73M shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, AVXL has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Donhauser Peter D.O. bought 2,835 shares of AVXL for 3.64 per share on Jun 14 ’24. After the transaction, the Director now owns 5,000 company shares. In a previous transaction on May 15 ’24, Thomas Steffen bought 5,000 shares at 4.52 per share. AVXL shares that Director owns now total 5,000.
Among the insiders who sold shares, MISSLING CHRISTOPHER U disposed of 73,380 shares on Mar 28 ’24 at a per-share price of $5.11. This resulted in the President and CEO holding 1,250,210 shares of AVXL after the transaction.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for AVXL in the last 3 months, the mean price target is $34.33 with high estimates of $46.00 and low estimates of $15.00. In terms of 52-week highs and lows, AVXL has a high of $14.44 and a low of $3.25.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. AVXL’s latest balance sheet shows that the firm has $152.11M in Cash & Short Term Investments as of fiscal 2021. Its Book Value Per Share was $1.31, while its Total Shareholder’s Equity was $150.82M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AVXL is Buy with a score of 5.00.
